Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-25 @ 5:21 PM
Study NCT ID:
NCT01829503
Status:
COMPLETED
Last Update Posted:
2019-11-14
First Post:
2013-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Sponsor:
Annie Im, M.D.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
12-099
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None